Search results
'Playing in the big leagues': P.E.I. fish health company sells for $1.3 billion
CBC via Yahoo News· 4 months agoAn international animal health company with facilities in Prince Edward Island has been sold to a...
Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson, Novo Nordisk, Roche and Novartis
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – June 1, 2023 – Today, Zacks Equity Research discusses Eli Lilly...
Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals
Zacks via Yahoo Finance· 4 months agoThe fourth-quarter earnings season entered its last lap this week, with Eli Lilly LLY and...
The Zacks Analyst Blog Highlights Merck, Salesforce, Philip Morris International, Novartis and CME...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – January 8, 2024 – Zacks.com announces the list of stocks...
Retirement Stock Portfolio: 11 Safe Healthcare Stocks to Consider
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we discuss the 11 safe healthcare stocks for a retirement stock portfolio. If you...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 4 weeks agoHEALTH NEWS Merck has struck a $1.3 billion deal to buy Eyebiotech, a move that would push the big...
It Happened in Crawford County: Ron Chatfield's career journey took him across the US
Telegraph-Forum via Yahoo News· 4 months agoRon Chatfield and his older sister, Judy, grew up in Columbus, the children of George and Ann...
3 Biotech Stocks Smart Investors Should Be Buying Up Now
InvestorPlace via Yahoo Finance· 2 years agoFor investors looking for growth, biotech stocks are a great place to start one’s search. This is a...
Zoetis Stock Rising — A Good Addition For Your Portfolio?
Investor's Business Daily· 7 months agoOn Thursday the Relative Strength (RS) Rating for Zoetis stock shot up from 69 to 76. After taking a...
2 Top Biotech Stocks to Buy Right Now
Motley Fool· 2 years agoHere are a couple of pharmaceutical stocks that are compelling buys for investors seeking a mix of income and growth prospects. Merck & Co.'s (NYSE: MRK)...